Penn MS - Search Results

1

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS. Askari AT, et al. Among authors: penn ms. Lancet. 2003 Aug 30;362(9385):697-703. doi: 10.1016/S0140-6736(03)14232-8. Lancet. 2003. PMID: 12957092

2

Quantitative evaluation of local drug delivery using the InfusaSleeve catheter.

Gottsauner-Wolf M, Jang Y, Penn MS, Kaplan A, Ellis SG, Chisolm GM, Topol EJ, Lincoff AM. Gottsauner-Wolf M, et al. Among authors: penn ms. Cathet Cardiovasc Diagn. 1997 Sep;42(1):102-8. doi: 10.1002/(sici)1097-0304(199709)42:1<102::aid-ccd27>3.0.co;2-r. Cathet Cardiovasc Diagn. 1997. PMID: 9286553

3

LDL increases inactive tissue factor on vascular smooth muscle cell surfaces: hydrogen peroxide activates latent cell surface tissue factor.

Penn MS, Patel CV, Cui MZ, DiCorleto PE, Chisolm GM. Penn MS, et al. Circulation. 1999 Apr 6;99(13):1753-9. doi: 10.1161/01.cir.99.13.1753. Circulation. 1999. PMID: 10190887

4

Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation.

Penn MS, Cui MZ, Winokur AL, Bethea J, Hamilton TA, DiCorleto PE, Chisolm GM. Penn MS, et al. Blood. 2000 Nov 1;96(9):3056-63. Blood. 2000. PMID: 11049984 Free article.

5

Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling.

Penn MS, Topol EJ. Penn MS, et al. Circ Res. 2001 Jul 6;89(1):1-2. doi: 10.1161/hh1301.093825. Circ Res. 2001. PMID: 11440969 No abstract available.

6

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention.

Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, Topol EJ, Ellis SG. Chew DP, et al. Among authors: penn ms. Circulation. 2001 Aug 28;104(9):992-7. doi: 10.1161/hc3401.095074. Circulation. 2001. PMID: 11524391

7

Association between myeloperoxidase levels and risk of coronary artery disease.

Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, Topol EJ, Sprecher DL, Hazen SL. Zhang R, et al. Among authors: penn ms. JAMA. 2001 Nov 7;286(17):2136-42. doi: 10.1001/jama.286.17.2136. JAMA. 2001. PMID: 11694155

8

Targeted gene therapy for the treatment of cardiac dysfunction.

Askari AT, Penn MS. Askari AT, et al. Among authors: penn ms. Semin Thorac Cardiovasc Surg. 2002 Apr;14(2):167-77. doi: 10.1053/stcs.2002.32320. Semin Thorac Cardiovasc Surg. 2002. PMID: 11988956 Review.

9

Autologous cell transplantation for the treatment of damaged myocardium.

Penn MS, Francis GS, Ellis SG, Young JB, McCarthy PM, Topol EJ. Penn MS, et al. Prog Cardiovasc Dis. 2002 Jul-Aug;45(1):21-32. doi: 10.1053/pcad.2002.123466. Prog Cardiovasc Dis. 2002. PMID: 12138412 Review.

10

Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion.

Wang K, Zhou X, Zhou Z, Tarakji K, Qin JX, Sitges M, Shiota T, Forudi F, Schaub RG, Kumar A, Penn MS, Topol EJ, Lincoff AM. Wang K, et al. Among authors: penn ms. Thromb Haemost. 2002 Jul;88(1):149-54. Thromb Haemost. 2002. PMID: 12152656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters